“The significance of Injective’s integration with Arbitrum extends beyond just building blockchain networks or infrastructure,” said Eric Chen, the co-founder of Injective Labs (and a speaker at this year’s Consensus festival), in the press release. “It enforces the fundamental principle of interoperability – closing the gap between Ethereum, Cosmos and other widely adopted L1s – for an ecosystem where cross-chain assets and liquidity can be truly composable across ecosystems.”
Nasdaq Biotech Firm Goes All-In on HYPE Token with Bold Treasury Bet
Key Takeaways:Sonnet BioTherapeutics announces a $888 million merger to launch a public HYPE token reserve.The new entity, Hyperliquid Strategies Inc...
